SYRIDEX BIO
Live / Applied — Statement of use — processing complete, to examiner (as of 29 Aug 2026)
What this means for you
Not registered yet, but its 25 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97978159
- Mark type
- Design + words
- Filed
- 25 Apr 2022
- Published for opposition
- 20 Jun 2023
- Attorney of record
- Gene K. Park
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of new and innovative pharmaceutical, biotechnology, and medical products
Owner
- Syridex Bio, LLC, Wilmington, DE, US
- Syridex Bio, LLC, Wilmington, DE, US
Prosecution history
- 09 Sept 2026 — ASSIGNED TO EXAMINER
- 29 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Aug 2026 — USE AMENDMENT FILED
- 11 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 01 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2026 — SOU EXTENSION 5 GRANTED
- 11 Feb 2026 — SOU EXTENSION 5 FILED
- 11 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Nov 2025 — SOU EXTENSION 4 GRANTED
- 11 Aug 2025 — SOU EXTENSION 4 FILED
- 11 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2025 — SOU EXTENSION 3 GRANTED
- 11 Feb 2025 — SOU EXTENSION 3 FILED